The forecast data for confirmed RR-/MDR-TB cases in Canada indicates stability, with predicted cases remaining at 16 annually from 2024 to 2026 before slightly declining to 15 in 2027 and 2028. This steadiness suggests a plateau, representing no significant year-on-year variation, consistent with past trends from 2023.

Over the five-year period ending in 2028, the compound annual growth rate (CAGR) reflects minimal change, underscoring the effectiveness of current TB control measures. However, a sustained focus on TB prevention and treatment, in combination with vigilant monitoring, will be vital in addressing any potential rise in drug-resistant cases influenced by unforeseen factors.

Future trends to monitor include: